One-Year Costs in Patients With a History of or at Risk for Atherothrombosis in the United States
暂无分享,去创建一个
Deepak L. Bhatt | Deepak L Bhatt | David J Cohen | K. Eagle | M. Alberts | E. Mahoney | D. Cohen | P. Steg | A. Hirsch | J. Jackson | P Gabriel Steg | Alan T Hirsch | Elizabeth M Mahoney | Kim Eagle | Kaijun Wang | Mark J Alberts | Frederique Mosse | Joseph D Jackson | Kaijun Wang | F. Mosse | D. Cohen | D. Cohen
[1] A. Ruhparwar. Spotlight: Arjang Ruhparwar, MD. Interview by Richard Hoey. , 2008, Circulation.
[2] K. Furie,et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.
[3] K. Furie,et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.
[4] Deepak L. Bhatt,et al. One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.
[5] Deepak L. Bhatt,et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. , 2006, American heart journal.
[6] Deepak L. Bhatt,et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. , 2006, JAMA.
[7] S. Yusuf,et al. Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation. , 2006, American heart journal.
[8] The High Concentration of U.S. Health Care Expenditures , 2006 .
[9] S. Yusuf,et al. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. , 2005, Journal of the American College of Cardiology.
[10] Elizabeth Selvin,et al. Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004, Circulation.
[11] H. Lazenby,et al. Age Estimates in the National Health Accounts , 2004, Health care financing review.
[12] I. Rubin. Information Agencies: Bureau of Labor Statistics and Bureau of the Census , 2003 .
[13] From the Centers for Disease Control and Prevention. Public health and aging: trends in aging--United States and worldwide. , 2003, JAMA.
[14] C. Cannon,et al. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. , 2002, JAMA.
[15] Eric R. Ziegel,et al. Generalized Linear Models , 2002, Technometrics.
[16] V. Fuster,et al. Epidemic of cardiovascular disease and stroke: the three main challenges. Presented at the 71st scientific sessions of the American Heart Association. Dallas, Texas. , 1999, Circulation.
[17] A. Folsom,et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. , 1998, The New England journal of medicine.
[18] W. Kannel. Risk Factors for Atherosclerotic Cardiovascular Outcomes in Different Arterial Territories , 1994, Journal of cardiovascular risk.